Frontiers | The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
The low-cost widely available drug that could fight COVID-19 - ANU
Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial
Inhaled Heparin: Therapeutic Efficacy and Recent Formulations | Journal of Aerosol Medicine and Pulmonary Drug Delivery
Nebulized Heparin For ARDS: Exploratory CHARLI Outcomes Point to Less Lung Injury, Earlier Return Home - Physician's Weekly
HEPBURN : investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial
Nebulized heparin for patients under mechanical ventilation: a conventional data meta-analysis | Critical Care | Full Text
PDF) Nebulized heparin and N-acetylcysteine for smoke inhalational injury: A case report
Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis | Annals of Intensive Care | Full Text
Can Nebulized Heparin Reduce Ventilator-Induced Lung Injury? |…
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): Protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies - Haren - 2021 - British
Inhaled Heparin: Therapeutic Efficacy and Recent Formulations | Journal of Aerosol Medicine and Pulmonary Drug Delivery
Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial | Critical Care | Full Text
Nebulized Heparin With N-Acetylcysteine and Albuterol Reduces Duration of Mechanical Ventilation in Patients With Inhalation Injury - Kaitlin A. McGinn, Katie Weigartz, Alicia Lintner, Michael J. Scalese, Steven A. Kahn, 2019
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro | Cell Discovery
Nebulized Heparin in COVID-19: a therapy worth investigating - St Vincent's Melbourne ICU
PDF) Role of Nebulized Heparin in Clinical Outcome of COVID-19 Patients with Respiratory Symptoms: A Systematic Review
Low-cost drug Heparin effective and safe treatment for COVID-19 - King's College London
Does Nebulized Unfractionated Heparin Cause changes in derived neutrophil to lymphocyte ratios in severe COVID-19 pneumonitis?
Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients | European Respiratory Society
Oral inhalation for delivery of proteins and peptides to the lungs - ScienceDirect
JCM | Free Full-Text | Anticoagulant Treatment in Severe ARDS COVID-19 Patients
Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia - The Lancet Respiratory Medicine
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID‐19: A multicentre case series of 98 patients - Haren - 2022 - British Journal of Clinical Pharmacology - Wiley Online Library
Use of Nebulized Heparin, Nebulized N-Acetylcysteine, and Nebulized Epoprostenol in a Patient With Smoke Inhalational Injury and Acute Respiratory Distress Syndrome - Kevin M. Dube, Kristen L. Ditch, Luanne Hills, 2017
